ArticleOncoTargets and therapy2016

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1.

Yebin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.